SREEKANTH DONEPUDI, MD, MP
SREEKANTH DONEPUDI
Phone: 3123305261
Email: [email protected]
Education/Training:
INSTITUTION AND LOCATION DEGREE
YEAR(s)
Kasturba Medical College, India, M.B.,B.S. 08/1996 - 02/2002
The University of Alabama at
Birmingham, Birmingham, Alabama
M.P.H.(Health Care
Organization and
Policy)
08/2002 - 05/2005
Advocate Illinois Masonic Medical
Center, Chicago, Illinois
Internal Medicine,
Residency
07/2005 - 06/2008
University of Nevada School of
Medicine, Reno, Nevada
Geriatric Medicine,
Fellowship
07/2008 - 06/2009
University of Nevada School of
Medicine, Reno, Nevada
Hospice and Palliative
Medicine, Fellowship
07/2009 - 06/2010
Nevada Cancer Institute, Las Vegas,
Nevada
Postdoctoral Fellow 07/2010 - 04/2011
Comprehensive Cancer Centers of
Nevada, Las Vegas, Nevada
Observership 05/2011 - 07/ 2012
University of Arizona, Tucson,
Arizona
Medical Oncology,
Fellowship
07/2012 – 06/2014
Certification/Licensure:
Board Certification: American Board of Internal Medicine , Medical Oncology
Work Experience:
03/2022- Current; Kansas City, MO
Medical oncologist, St Luke's Cancer Institute
07/2014 –02/2022; Pierre, South Dakota
Medical oncologist, Avera St Mary’s Hospital
Clinical Assistant Professor, University of South Dakota, SDResearch Experience:
2020- 2022, Clinical Investigator
S1418/BR006, A Randomized, Phase III Trial To Evaluate The Efficacy And Safety Ofmk-3475
(Pembrolizumab) As Adjuvant Therapy For Triple Receptor-NegaRve Breast Cancer With ≥ 1 Cm Residual
Invasive Cancer Or PosiRve Lymph Nodes (Ypn1Mi, Ypn1-3) AYer Neoadjuvant Chemotherapy
PROTOCOL B-59/GBG 96-GeparDouze;A Randomized, Double-Blind, Phase III Clinical Trial of
Neoadjuvant Chemotherapy with Atezolizumab or Placebo in PaRents with Triple-NegaRve
Breast Cancer Followed by Adjuvant ConRnuaRon of Atezolizumab or Placebo
7/2010 - 4/2011; Nevada Cancer Institute, Las Vegas
Postdoctoral Fellow, Supervisor: Wolfram Samlowski, M.D, Dept of Melanoma
Study: Isolation and characterization of circulating tumor cells in Melanoma
2/2009 - 6/2010; University of Nevada, Reno
Postdoctoral Fellow, Supervisor: Graça D. Almeida-Porada, M.D., Ph.D, Dept of
Animal Biotechnology
Study: Evaluate the inhibitory effect of Mesenchymal stem cell (MSC) on Proliferation
of Cancer cells utilizing Co-cultures of MSC and Leukemic cells.
10/2008 - 6/2010; VA Sierra Health Care, Nevada
Geriatrics Fellow, Supervisor: Roy F. Mackintosh, M.D., Ph.D, Dept of Hematology/Oncology
Sub-investigator: Paclitaxel poliglumex (CT-2103)/Carboplatin vs. Paclitaxel/Carboplatin for
the treatment of chemotherapy-naïve advanced Non-Small Cell Lung Cancer (NSCLC) in
Women with Estradiol >25 pg/mL.
Sub-investigator: Study of Avastin (Bevacizumab) in combination with chemotherapy for
treatment of metastatic or locally advanced and unresectable colorectal cancer, locally
advanced or metastatic non-small cell lung (excluding predominant sqaumous cell histology)
or locally recurrent or metastatic breast cancer.
08/2007 - 08/2007; University of Chicago, Illinois
Research Assistant, Supervisor: Lucy A. Godley, M.D.,Ph.D, Dept of Hematology/Oncology
Study: Review of hypomethylating agents and HDAC inhibitors in hematological and solid
tumors
07/2004 - 05/2005; University of Alabama at Birmingham, Alabama
Research Assistant, Supervisor: Kevin Dybvig, M.D.,Ph.D, Dept of Genomics
Study: Novel genetic loci in M. pulmonis that encode phase-variable (on/off switching)
enzymes that modify DNA (restriction and modification enzymes).
02/2005 - 03/2005; University of Alabama at Birmingham, Alabama
Research Assistant, Supervisor: Carla Falkson, MD, Dept of Hematology/Oncology
Study: Identifying operational and cost benchmarks in cancer clinical trials.Awards & Certificates:
2009&2010 US Senator Harry Reid Certificate of Commendation
2009& 2010 Certificate of Special Congressional Recognition
2010 Senatorial Certificate of Achievement
2010 Recipient of Graham and Jean Sanford Scholarship
2010 Veridex (Cell Search) research fellow Award
Publications / Presentations:
Book Chapter
1. Chau D, Blanchette P, Donepudi S, Dopf R (December 2010). Chapter Title: Assessing
Decisional Capacity in Older Adults, Book Title: Case Based Geriatrics-A Global Approach,
Publisher: McGraw Hill, Chief Editor: Victor Hirth.
Peer Reviewed Online Publication
1. Donepudi S, Mattison R J, Kihslinger J, Godley L A. (2007, December). Modulators of DNA
methylation and histone acetylation.
(http://www.sciencedirect.com/science/article/pii/S1872115X07000497)
2. Sreekanth Donepudi, Ronald C. DeConti, Wolfram E. Samlowski (2012, April). Recent
Advances in the Understanding of the Genetics, Etiology, and Treatment of Merkel Cell
Carcinoma. (http://www.seminoncol.org/article/S0093-7754 (12) 00004-8)
3. Sreekanth Donepudi, Susan A. Reisinger, John R. McGregor, Shweta Tharkar, Suzanne
Samlowski, Daniel Ostler, Shirley Shen(2013, September). Circulating Tumor Cell Cultures
as a Predictive Marker during Salvage Therapy of Refractory Merkel Cell Carcinoma with
Chemotherapy and Electron Beam Radiation
(http://dx.doi.org/10.4236/jct.2013.47135)
Abstract Publications/ Presentations
1. John R. McGregor, Wolfram E. Samlowski, Shweta Tharkar, Sreekanth Donepudi, Soldano
Ferrone (2012, June). Isolation and expansion of circulating tumor cells (CTC) from
melanoma patients using a novel cell culture technique. Poster presented at: ASCO
(American Society of Clinical Oncology) Annual Meeting 2012; Chicago, Illinios.
2. Donepudi S, Poroda C, Zanjani,E., Almeida-Porada G. (2010, April). Mesenchymal stem
cell subset prevents cycling of KG1a leukemic cells by cell-cell interaction. Poster
presented at: AACR (American Association of Cancer Research) 101st Annual Meeting 2010;
Washington, DC.
3. Phyu K, Donepudi S, Chau D, Shumaker N (October, 2009) Drug-drug interaction with
methadone. Fifth Annual Chicago Supportive Oncology Conference, Chicago, Illinois.
(http://www.supportiveoncology.net/journal/articles/0705194.pdf)4. Donepudi S, Joseph D, Yang W, Chau D (2009, September). Colon Cancer Screening
Disparities in Nevada. Nevada Public Health Association, Reno, Nevada.
5. Phyu K, Donepudi S, Agustin T (2009, June). Fracture risk assessment: A clinical
application in the V.A community living center. Abstract presented at the Resident’s
research Day, UNR, Reno, Nevada.
6. Neila Shumaker, Diane Chau, Khine Phyu, Sreekanth Donepudi (March 2010).
Interdisciplinary Team (IDT) Approach to Teaching Geriatric Pain Management in a Long
Term Care Setting. 36th Annual Meeting of the Association for Gerontology in Higher
Education
7. Diane Chau, Patricia May, Sreekanth Donepudi, Khine Phyu (March 2010). Teaching
Geriatrics to Surgery Trainees using Case Based and Web based Education. 36th Annual
Meeting of the Association for Gerontology in Higher Education
8. Patricia Swager, Patricia Charles, Diane Chau, Sreekanth Donepudi, (November 2009)
Creative Approaches to Provider Education for Healthy Aging. 62nd Annual Scientific
Meeting of the Gerontological Society of America.
Oral Presentation
1. Donepudi S. (2008, April). Advances in Cancer treatment, including modulators of DNA
methylation and histone acetylation. Oral Presentation presented at: Senior Research
Project, Advocate Illinois Masonic Medical Center; Chicago, IL.
2. Donepudi S. (July 2008 - June 2010). Polypharmacy, Dementia, Delirium, Depression.
Oral Presentations presented at: Nevada Geriatric Education Center; Reno, NV.
3. Donepudi S. (2010). Grand Rounds - Decision Capacity
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:02/13/2025Date updated:02/13/2025